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Negative studies are helpful 
to compute the specificity of diagnostic tests: 
measuring Trypanosoma cruzi seroprevalence 
in Guanajuato, Mexico
Nicolás Padilla‑Raygoza1*, Rubí Gamboa‑León2, Maria Jesus Ramirez‑Sierra3, Eric Dumonteil3, Pierre Buekens4, 
Ma Laura Ruiz‑Paloalto5 and Rosalina Diaz‑Guerrero6
Abstract 
Background: Publishing negative seroprevalence studies not only helps to have more accurate seroprevalence 
estimates but also allows calculating the specificity of the diagnostic tests used. We performed a population‑based 
Trypanosoma cruzi seroprevalence survey in a community in central Mexico.
Results: We surveyed 204 women and children and collected blood by finger prick. We performed rapid tests (Stat‑
Pak, Chembio, Inc., Medford, New York) and recombinant Chagas ELISA tests v3.0 (Wiener, Rosario, Argentina). All rapid 
tests and all ELISA tests were negative.
Conclusion: The rapid test had 100 % of specificity compared to the ELISA.
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Results
Results of negative seroprevalence studies are often not 
published. Finding no infected individual in a commu-
nity might be disappointing to the infectious diseases 
researcher, which might induce a strong publication bias. 
Yet, publishing such negative studies not only helps to 
have more accurate seroprevalence estimates but also 
allows calculating the specificity of the diagnostic tests 
used. Specificity is defined as the proportion of non-
infected individuals correctly identified as negative by the 
test [1]. The results of the test under evaluation need to 
be compared to a gold standard: at least two tests need to 
be performed on each sample to calculate specificity.
Chagas’ disease, or American trypanosomiasis, is 
caused by the protozoan parasite Trypanosoma cruzi and 
is a major cause of morbidity and mortality in endemic 
countries in Latin America. It is estimated that 6–7 mil-
lion people are infected in Latin America [2]. Two positive 
serological tests are needed to confirm chronic Chagas’ 
disease. There is some uncertainty about T. cruzi sero-
prevalence in Mexico [3–6]. In 2008, we performed a 
population-based household T. cruzi seroprevalence study 
among women of reproductive age and their children in 
Estancia del Llano, Guanajuato, Mexico, where we had 
identified two seropositive pregnant women in a previ-
ous study [7]. In 2005, Estancia del Llano had a population 
of 1859 inhabitants, 203 of whom were children under 
5  years and 530 of whom were women of reproductive 
age, including 17 pregnant women [8]. We used Epi Info 
3.3.2 (Centers for Disease Control, Atlanta, GA) to calcu-
late that a sample of 185 women of reproductive age and 
children would allow us to measure a seroprevalence of 
0.5 % with a possible high result of 2 %, with a 99 % confi-
dence interval and a 1.5 design factor taking into account 
the cluster sampling. We surveyed 177 homes from 13 
blocks in the community. We contacted 204 people living 
within the selected households; 42 of them were under 
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5  years, 157 were non-pregnant women of childbear-
ing age (12–49  years), and five were pregnant women. 
Data were collected on forms designed specifically for 
the study. Labels with de-identified study numbers were 
pasted on data collection forms and blood samples.
After obtaining informed consent, blood was collected 
by finger prick. Stat-Pak (Chembio, Inc., Medford, New 
York) rapid tests were performed and filter paper was 
impregnated with capillary blood for further study. The 
filter papers collected each day were stored in the Gen-
eral Hospital Celaya clinical laboratory and kept frozen 
at −20  °C until shipment to the laboratory of parasitol-
ogy, Centro de Investigaciones Regionales (CIR) “Dr. 
Hideyo Noguchi” at the Autonomous University of Yuca-
tán, where recombinant ELISA Chagas Wiener (Rosario, 
Argentina) v3.0 was used according to the manufacturer’s 
instructions. Samples were assayed in duplicate on two 
different ELISA plates, with each plate including one 
blank (without sample), two positive controls (human 
serum with antibodies anti-T. cruzi), and three negative 
controls (human serum without antibodies anti-T. cruzi) 
from the manufacturer (Table  1). The corrected Opti-
cal Densities (ODs) were obtained with OD sample less 
OD blank. The results of the two plates were validated 
because the optical densities were <0.150 OD for at least 
two corrected negative controls and ≥0.600 for the aver-
age corrected positive controls (Table 1). The cut-off for 
each ELISA plate was the average OD of the corrected 
negative control +0.3, as defined by the manufacturer’s 
instructions, and the indeterminate zones were deter-
mined as specified by the manufacturer as well.
All 204 rapid tests were negative. Using the ELISA as 
gold standard, we calculated a 100  % specificity for the 
Stat-Pak rapid test. The specificity of 100  % rapid test 
study is consistent with the specificity reported by Sosa 
et al. for the same rapid test compared to the same gold 
standard: 99.4 % in Argentina, 98.6 % in Bolivia, 97.5 % in 
Honduras, and 99.6 % in Mexico [7]. We concluded that 
the Stat-Pak is a highly specific rapid test for use in pop-
ulation-based surveys in Mexico and is useful to rule out 
Chagas’ disease infection in different geographic areas. 
The results suggest that the prevalence of Chagas’ disease 
is low in Guanajuato, Mexico.
The protocol was reviewed and approved by Research 
and Bioethics Committee of the School of Nursing and 
Obstetrics of Celaya, University of Guanajuato, and by 
the IRB of the School of Public Health and Tropical Med-
icine of Tulane University in New Orleans, USA.
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Table 1 Results of the ELISA plates for 204 blood samples
ELISA plate #1 ELISA plate #2
Blank 0.035 0.036
Corrected negative control 1 0.011 0.002
Corrected negative control 2 −0.003 0.008
Corrected negative control 3 0.003 −0.002
Average positive controls 1.000 1.000
Cut off 0.303 0.302
Cut off ± 10 %  
(indeterminate)
Upper limit = 0.334
Lower limit = 0.273
Upper limit = 0.333
Lower limit = 0.272
Corrected sample results 
(n = 204)
−0.014 to 0.026 −0.003 to 0.022
